Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the Pediatric HIV/AIDS Cohort Study
- PMID: 25742077
- PMCID: PMC4365792
- DOI: 10.1097/INF.0000000000000598
Distortion product otoacoustic emission data in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents in the Pediatric HIV/AIDS Cohort Study
Abstract
The effect of perinatal HIV infection and exposure on sub-clinical auditory function can be measured with distortion product otoacoustic emissions (DPOAEs). DPOAEs were obtained at 4 frequency bins (1, 2, 3 and 4 kHz) and categorized by a signal-to-noise ratio. HIV infection was not associated with poorer DPOAEs. Among HIV-infected children, HIV viral load≥400 copies/mL had significantly lower odds of better DPOAEs.
References
-
- Lucertini M, Moleti A, Sisto R. On the detection of early cochlear damage by otoacoustic emission analysis. J Acoust Soc Am. 2002;111:972–978. - PubMed
-
- Marshall L, Lapsley Miller JA, Heller LM. Distortion-product otoacoustic emissions as a screening tool for noise-induced hearing loss. Noise Health. 2001;3:43–60. - PubMed
-
- Manfredi AS, Zuanetti PA, Mishima F, Granzotti RBG. Newborn hearing screening in infants born to HIV-seropositive mothers. J Soc Bras Fonoaudiol. 2011;23:376–80. - PubMed
-
- Olysanya BO, Afe AJ, Onyia NO. Infants with HIV-infect mothers in a universal newborn hearing screening programme in Lagos, Nigeria. Acta Paeditrica. 2009;98:1288–1293. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
